Eagles’ Jalen Hurts Anticipated To Miss Rest Of Season After Blood Clots Found In Lungs

It’s anticipated that Philadelphia Eagles quarterback Jalen Hurts will miss the rest of the 2026 season following doctors discovering numerous blood clots in his lungs, according to ESPN’s Adam Schefter and NFL Network’s Ian Rapoport.

Hurts will receive treatment that involves blood thinners, and it’s expected that it will sideline him for at least three months, according to Schefter’s and Rapoport’s sources. (RELATED: Jim Harbaugh Says Chargers Need ‘To Address Everything’ After Getting Smashed In Another Loss)

Nicole Lynn, Hurts’s agent, and the Eagles organization issued a statement Monday that details what the quarterback is experiencing. Lynn and Philadelphia stated that Hurts has deep vein thrombosis and bilateral pulmonary emboli, which means a blood clot went from the QB’s legs to his lungs.

https://t.co/aInIuUYiQJ

According to the statement, Hurts is “clinically stable and has no significant functional limitations,” however, he won’t be permitted to participate in football activities while taking anticoagulation medication.

“Jalen’s prognosis is very good, and we expect a full recovery,” reads the statement. “We anticipate that he will have the opportunity to resume contact football activities when off the blood thinners. In the meantime, he will remain active around the team and continue to condition. More importantly, we anticipate that he will have no long-term effects.”

Initially, Hurts was diagnosed with what was branded as a superficial blood clot located in his calf. The quarterback’s diagnosis took place in London prior to Philadelphia’s Week 5 contest against the Jacksonville Jaguars, which was played at Tottenham Hotspur Stadium. Ultimately a 19-17 defeat for the Eagles; Hurts played in the contest despite receiving the original diagnosis, attempting 40 passes.